Nephraegis Therapeutics

0 followers

Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).

Employees

1-10

Links


Org chart

CEO
Collapse
Chief Development officer

Teams

This company has no teams yet